CVE:QHR - 4155 (QHR.V) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New 4155 (QHR.V) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for QHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for QHR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$0.00
This price target is based on 0 analysts offering 12 month price targets for 4155 (QHR.V) in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in 4155 (QHR.V). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/25/2020

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
8/22/2016Paradigm CapitalDowngradeBuy ➝ TenderC$2.75 ➝ C$3.10
i
8/19/2016Paradigm CapitalBoost Price TargetBuy ➝ TenderC$2.75 ➝ C$3.10
i
6/7/2016Paradigm CapitalBoost Price TargetBuyC$2.10 ➝ C$2.25
i
5/16/2016Cantor FitzgeraldUpgradeHold ➝ Buy
i
Rating by R. Garcea at Cantor Fitzgerald
3/21/2016Laurentian Bank of Canada (LB.TO)Boost Price TargetBuyC$1.75 ➝ C$2.00
i
3/21/2016LaurentianBoost Price TargetBuyC$1.75 ➝ C$2.00
i
(Data available from 11/25/2015 forward)
4155 (QHR.V) logo
QHR Corp is a Canada-based healthcare technology company. The Company's principal business consists of electronic medical records applications and hosting for physicians' medical offices, and revenue cycle management software solutions and transaction processing services to physicians, hospitals, health plans, insurance brokers and state governments to exchange information for health plan enrolment, eligibility and claims. The Company's product portfolio includes AccuroEMR and Medeo. AccuroEMR is an Electronic Medical Records (EMR) platform in Canada, offering clinics a range of integrated functionality, including scheduling, billing, prescriptions, chronic disease management tools, data reporting, secure messaging and mobile touch screen access. Its AccuroEMR is available as a direct installation or on software as a service (SaaS) basis. Its Medeo's virtual care software delivers messaging, video conferencing, collaboration and telemedicine functionality to healthcare providers.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

363,377 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A